Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125529341 | 12552934 | 1 | I | 20160708 | 20160713 | 20160713 | EXP | JP-SCIEGEN PHARMACEUTICALS INC-2016SCILIT00317 | SCIEGEN | 62.00 | YR | F | Y | 0.00000 | 20160713 | PH | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125529341 | 12552934 | 1 | PS | CLOPIDOGREL | CLOPIDOGREL BISULFATE | 1 | Unknown | 75 MG, QD | U | 204165 | 75 | MG | TABLET | ||||||
125529341 | 12552934 | 2 | I | PACLITAXEL. | PACLITAXEL | 1 | Unknown | 96 MG PER WEEK | U | 0 | 96 | MG | |||||||
125529341 | 12552934 | 3 | SS | Nedaplatin | NEDAPLATIN | 1 | Unknown | 75 MG/M2, UNK | U | U | 0 | 75 | MG/M**2 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125529341 | 12552934 | 1 | Angina pectoris |
125529341 | 12552934 | 2 | Ovarian cancer |
125529341 | 12552934 | 3 | Ovarian cancer |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125529341 | 12552934 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125529341 | 12552934 | Drug interaction | |
125529341 | 12552934 | Neutropenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |